Pixu Liu

Brigham and Women's Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index5.5kcitations57works7.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PI3K/AKT/mTOR signaling in cancer(7), RNA modifications and cancer(7), MicroRNA in disease regulation(4), DNA Repair Mechanisms(4), Estrogen and related hormone effects(4)

Publications57 total

Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients
BMC Gastroenterology·2025Open Access
Editorial Expression of Concern: Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis
Nature·2025· 1 citedOpen Access
SGK1 suppresses ferroptosis in ovarian cancer via NRF2-dependent and -independent pathways
Oncogene·2024· 9 cited
Enzalutamide Sensitizes Castration‐Resistant Prostate Cancer to Copper‐Mediated Cell Death
Advanced Science·2024· 24 citedOpen Access
Presenilin 1 Is a Therapeutic Target in Pulmonary Hypertension and Promotes Vascular Remodeling
American Journal of Respiratory Cell and Molecular Biology·2024· 2 cited
Inhibition of palmitoyltransferase <scp>ZDHHC12</scp> sensitizes ovarian cancer cells to cisplatin through <scp>ROS</scp>‐mediated mechanisms
Cancer Science·2024· 17 citedOpen Access
Mi-BMSCs alleviate inflammation and fibrosis in CCl4-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signaling
Materials Today Bio·2024· 7 citedOpen Access
Diagnostic value of serum inflammatory markers in predicting early refractoriness of transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer Stage 0, A, and B hepatocellular carcinoma
Brazilian Journal of Medical and Biological Research·2024Open Access
The SGK3-Catalase antioxidant signaling axis drives cervical cancer growth and therapy resistance
Redox Biology·2023· 15 citedOpen Access
Data from A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR Inhibition
2023Open Access
Supplementary Figures 1 - 11 from A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR Inhibition
2023Open Access
Supplementary Figures 1 - 11 from A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR Inhibition
2023Open Access
Supplementary Table S1 from A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR Inhibition
2023Open Access
Data from A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR Inhibition
2023Open Access
Supplementary Table S1 from A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR Inhibition
2023Open Access
Engineered Apoptosis-Bioinspired Nanoparticles Initiate Immune Cascade for Cancer Immunotherapy of Malignant Ascites
ACS Applied Materials & Interfaces·2023· 11 cited
Pangenomic analysis of Chinese gastric cancer
Nature Communications·2022· 29 citedOpen Access
Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells
Frontiers in Oncology·2022· 10 citedOpen Access
Microbiota dysbiosis in pancreatic cancer: evidence ofassociation and tumorigenesis
Scientia Sinica Vitae·2021
Melatonin potentiates the cytotoxic effect of Neratinib in HER2+ breast cancer through promoting endocytosis and lysosomal degradation of HER2
Oncogene·2021· 36 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Hailing Cheng(22), Jean J. Zhao(13), Xiaolin Sang(8), Fuwen Luo(8), Thomas M. Roberts(7), Jingyan Yi(6), Min Wang(5), Lanlin Shen(5), Yijue Xue(5), Chongya Liu(4), Zhiwei Tao(4), Yuan Zhang(4), Zhijie Yu(4), Shidong Jia(3), Zhenning Liu(3), Sang‐Hyun Lee(3), Sabina Signoretti(3), Massimo Loda(3), Gordon B. Mills(3), Yaxun Jia(3)